Regenerative Medicine for Tendon/Ligament Injuries: De Novo Equine Tendon/Ligament Neotissue Generation and Application
Authors: Takashi Taguchi
Summary
# Editorial Summary: Regenerative Medicine for Tendon/Ligament Injuries Tendon and ligament injuries present a significant clinical challenge in equine practice due to the inherently poor regenerative capacity of these tissues, limiting restoration of functional biomechanics. Taguchi's 2023 work advances the field through a multi-phase investigation, beginning with meta-analysis of cellular administration outcomes before progressing to engineer implantable de novo tendon neotissue constructed from equine adipose-derived multipotent stromal cells combined with type I collagen scaffold. Preclinical biocompatibility and immunogenicity testing utilised both immunocompetent and immunocompromised rat models, establishing safety parameters before translating findings to an equine surgical model of accessory ligament of the deep digital flexor tendon injury. The engineered neotendon demonstrated therapeutic efficacy in restoring structural integrity and function in the target equine injury model, offering a scaffold-based regenerative approach that circumvents limitations of conventional cell therapy alone. For equine practitioners, these findings suggest that engineered tendon neotissue may provide a reproducible, autologous cell-derived treatment option for addressing the chronic functional deficits associated with high suspensory apparatus injuries, though clinical validation in the field remains necessary before widespread adoption.
Read the full abstract on the publisher's site
Practical Takeaways
- •Cell-based regenerative therapy may offer new options for treating tendon and ligament injuries in horses that currently have poor healing outcomes
- •Engineered tendon tissue using a horse's own fat-derived cells combined with collagen showed promise in preclinical models and warrants further clinical investigation
- •This multi-stage research approach (meta-analysis, tissue engineering, animal models) demonstrates the pathway from concept to potential clinical application for equine soft tissue injuries
Key Findings
- •Meta-analysis evaluated cellular administration effects on equine tendon/ligament injuries
- •De novo tendon neotissue was successfully engineered using equine adipose-derived multipotent stromal cells and collagen type I
- •Neotendon demonstrated biocompatibility in both immunocompetent and immunocompromised rat models
- •Engineered neotendon showed therapeutic potential in surgically-induced equine accessory ligament injury model